Show results for
Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Retinal Disease Suppliers In Usa
13 companies found
based inWaltham, MASSACHUSETTS (USA)
Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases. Existing therapies for retinal neovascular / exudative diseases have made great ...
Kalaris Therapeutics is focused on developing innovative treatments for retinal diseases, aiming to reduce the burden of frequent clinical visits for patients with retinal neovascular and exudative ...
based inJacksonville, FLORIDA (USA)
Marco is a leader in Ophthalmic Vision Diagnostic Equipment for eye-care professionals. Marco has been a leader in offering eye-care professionals the very finest in a complete range of traditional vision diagnostic equipment. Take your practice to ...
The latest in retinal imaging technology, the AFC-330 breaks new ground in fundus photography with emphasis on capturing the perfect picture every time, regardless of operator experience or skill level. The AFC-330 sets a new standard in speed, ...
based inFranklin, MASSACHUSETTS (USA)
Heidelberg Engineering continuously optimizes imaging and healthcare IT technologies to provide ophthalmic diagnostic solutions that empower clinicians to improve patient care. From its inception in 1990, the company has collaborated with ...
The SPECTRALIS® High Magnification Module consists of a highly innovative magnifying lens and software. It elegantly demonstrates the capability of confocal scanning laser ophthalmoscopy (cSLO) to resolve ocular microstructures by reducing ...
based inMadison, WISCONSIN (USA)
Retinal degenerative diseases cause irreversible vision loss in tens of millions of patients worldwide. Our mission at Opsis Therapeutics is to advance a pipeline of first-in-class cell replacement therapies targeting Age-Related Macular ...
based inMountain View, CALIFORNIA (USA)
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We ...
Dual port green laser for comprehensive ophthalmology. NEW- MicroPulse® Laser Therapy for repeatable, tissue-sparing* glaucoma and retinal ...
based inMalvern, PENNSYLVANIA (USA)
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. Our breakthrough modifier gene therapy platform ...
OCU400 (AAV-NR2E3) is a novel gene therapy product candidate with the potential to be broadly effective in restoring retinal integrity and function across a range of genetically diverse inherited retinal ...
based inWaltham, MASSACHUSETTS (USA)
BVI is refocusing the future of vision. As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio of trusted brands includes: Beaver (Knives and Blades), Visitec (Cannulas), Malosa ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Faricimab, an overall good safety and tolerability profile, is a bispecific antibody targeting Angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Faricimab prevents retinal vascular leakage, cell death and ...
based inMinneapolis, MINNESOTA (USA)
Since 1985, we've made it our mission to help address the treatment needs and transform the sight of people across the globe. From the introduction of the first Ellex ophthalmic laser in 1987, through to our partnership with some of the world's ...
Featuring a proprietary dual-mode laser cavity, Integre Pro™ delivers uniform energy distribution across the full spot diameter, eliminating hotspots and achieving optimal, homogenous burns. It’s a key feature that means you can achieve ...
based inManassas, VIRGINIA (USA)
Notal Vision is the first diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes. By applying artificial intelligence (AI)-driven data interpretation to the unprecedented high volumes of ...
The Notal OCT Analyzer (NOATM) is a computational image analysis algorithm designed to provide automated detection of fluid in exudative retinal diseases including wet Age-Related Macular Degeneration, macular ...
based inBridgewater, NEW JERSEY (USA)
Bausch + Lomb, a division of Bausch Health Companies Inc., (NYSE:BHC) (TSX:BHC), is solely dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our ...
based inSan Clemente, CALIFORNIA (USA)
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. At Glaukos, our focus is to develop and lead the ...
based inCambridge, MASSACHUSETTS (USA)
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition. Until recently, scientists believed that mature adult cells were permanently locked into their ...
With our cell+gene platform, BlueRock is aiming to redefine the very way we treat disease, moving from addressing mere symptoms to restoring health lost to cell damage or degeneration. Instead of prescribing a pill to treat tremors in patients with ...